Literature DB >> 26134898

An ALS disease mutation in Cdc48/p97 impairs 20S proteasome binding and proteolytic communication.

Dominik Barthelme1, Ruben Jauregui1, Robert T Sauer1.   

Abstract

Cdc48 (also known as p97 or VCP) is an essential and highly abundant, double-ring AAA+ ATPase, which is ubiquitous in archaea and eukaryotes. In archaea, Cdc48 ring hexamers play a direct role in quality control by unfolding and translocating protein substrates into the degradation chamber of the 20S proteasome. Whether Cdc48 and 20S cooperate directly in protein degradation in eukaryotic cells is unclear. Two regions of Cdc48 are important for 20S binding, the pore-2 loop at the bottom of the D2 AAA+ ring and a C-terminal tripeptide. Here, we identify an aspartic acid in the pore-2 loop as an important element in 20S recognition. Importantly, mutation of this aspartate in human Cdc48 has been linked to familial amyotrophic lateral sclerosis (ALS). In archaeal or human Cdc48 variants, we find that mutation of this pore-2 residue impairs 20S binding and proteolytic communication but does not affect the stability of the hexamer or rates of ATP hydrolysis and protein unfolding. These results suggest that human Cdc48 interacts functionally with the 20S proteasome.
© 2015 The Protein Society.

Entities:  

Keywords:  AAA+ machine; ATP-dependent degradation; proteasome; protein unfolding

Mesh:

Substances:

Year:  2015        PMID: 26134898      PMCID: PMC4570545          DOI: 10.1002/pro.2740

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Dynamics of substrate denaturation and translocation by the ClpXP degradation machine.

Authors:  Y I Kim; R E Burton; B M Burton; R T Sauer; T A Baker
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  Architecture and assembly of the archaeal Cdc48*20S proteasome.

Authors:  Dominik Barthelme; James Z Chen; Jonathan Grabenstatter; Tania A Baker; Robert T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 3.  Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.

Authors:  Hemmo Meyer; Monika Bug; Sebastian Bremer
Journal:  Nat Cell Biol       Date:  2012-02-02       Impact factor: 28.824

4.  Stepwise unfolding of a β barrel protein by the AAA+ ClpXP protease.

Authors:  Andrew R Nager; Tania A Baker; Robert T Sauer
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

5.  Imbalances in p97 co-factor interactions in human proteinopathy.

Authors:  Vanesa Fernández-Sáiz; Alexander Buchberger
Journal:  EMBO Rep       Date:  2010-04-23       Impact factor: 8.807

6.  Nucleotide dependent motion and mechanism of action of p97/VCP.

Authors:  Byron DeLaBarre; Axel T Brunger
Journal:  J Mol Biol       Date:  2005-03-25       Impact factor: 5.469

Review 7.  Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Authors:  Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-04-19       Impact factor: 4.296

8.  Reconstitution of the 26S proteasome reveals functional asymmetries in its AAA+ unfoldase.

Authors:  Robyn Beckwith; Eric Estrin; Evan J Worden; Andreas Martin
Journal:  Nat Struct Mol Biol       Date:  2013-09-08       Impact factor: 15.369

9.  Dynamic and static components power unfolding in topologically closed rings of a AAA+ proteolytic machine.

Authors:  Steven E Glynn; Andrew R Nager; Tania A Baker; Robert T Sauer
Journal:  Nat Struct Mol Biol       Date:  2012-05-06       Impact factor: 15.369

Review 10.  Cleaning up in the endoplasmic reticulum: ubiquitin in charge.

Authors:  John C Christianson; Yihong Ye
Journal:  Nat Struct Mol Biol       Date:  2014-04       Impact factor: 18.361

View more
  9 in total

Review 1.  Assessing heterogeneity in oligomeric AAA+ machines.

Authors:  Tatyana A Sysoeva
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

Review 2.  Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication.

Authors:  Kristijan Ramadan; Swagata Halder; Katherine Wiseman; Bruno Vaz
Journal:  Chromosoma       Date:  2016-04-18       Impact factor: 4.316

Review 3.  Gates, Channels, and Switches: Elements of the Proteasome Machine.

Authors:  Daniel Finley; Xiang Chen; Kylie J Walters
Journal:  Trends Biochem Sci       Date:  2015-11-28       Impact factor: 13.807

Review 4.  Origin and Functional Evolution of the Cdc48/p97/VCP AAA+ Protein Unfolding and Remodeling Machine.

Authors:  Dominik Barthelme; Robert T Sauer
Journal:  J Mol Biol       Date:  2015-12-01       Impact factor: 5.469

5.  p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.

Authors:  Katrin Schweitzer; Alexander Pralow; Michael Naumann
Journal:  J Cell Mol Med       Date:  2015-10-14       Impact factor: 5.310

6.  Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum.

Authors:  Hamideh Shahheydari; Audrey Ragagnin; Adam K Walker; Reka P Toth; Marta Vidal; Cyril J Jagaraj; Emma R Perri; Anna Konopka; Jessica M Sultana; Julie D Atkin
Journal:  Front Mol Neurosci       Date:  2017-05-10       Impact factor: 5.639

Review 7.  Biological and Pathological Implications of an Alternative ATP-Powered Proteasomal Assembly With Cdc48 and the 20S Peptidase.

Authors:  Masatoshi Esaki; Ai Johjima-Murata; Md Tanvir Islam; Teru Ogura
Journal:  Front Mol Biosci       Date:  2018-06-08

8.  The Cdc48 unfoldase prepares well-folded protein substrates for degradation by the 26S proteasome.

Authors:  Michal M Olszewski; Cameron Williams; Ken C Dong; Andreas Martin
Journal:  Commun Biol       Date:  2019-01-21

Review 9.  Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

Authors:  Christopher P Webster; Emma F Smith; Pamela J Shaw; Kurt J De Vos
Journal:  Front Mol Neurosci       Date:  2017-05-02       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.